buspirone has been researched along with Somatoform Disorders in 5 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 9.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| "The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial." | 9.08 | Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997) |
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 5.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| "The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial." | 5.08 | Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badihian, N | 1 |
| Yaghini, O | 1 |
| Badihian, S | 1 |
| Shahsanai, A | 1 |
| Saneian, H | 1 |
| Phillips, KA | 3 |
| Hollander, E | 1 |
| Mitsikostas, DD | 1 |
| Gatzonis, S | 1 |
| Thomas, A | 1 |
| Ilias, A | 1 |
| Albertini, RS | 1 |
| Siniscalchi, JM | 1 |
| Khan, A | 1 |
| Robinson, M | 1 |
2 reviews available for buspirone and Somatoform Disorders
| Article | Year |
|---|---|
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
Topics: Body Image; Buspirone; Cognitive Behavioral Therapy; Drug Administration Schedule; Drug Therapy, Com | 2008 |
Pharmacologic treatment of body dysmorphic disorder.
Topics: Adult; Buspirone; Humans; Male; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders | 1996 |
2 trials available for buspirone and Somatoform Disorders
| Article | Year |
|---|---|
Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial.
Topics: Abdominal Pain; Adolescent; Anxiety; Buspirone; Child; Depression; Female; Humans; Male; Pain Measur | 2020 |
Buspirone vs amitriptyline in the treatment of chronic tension-type headache.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Buspirone; Dep | 1997 |
1 other study available for buspirone and Somatoform Disorders
| Article | Year |
|---|---|
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administ | 2001 |